A prominent Chinese scientific journal has published a paper detailing the development of synthetic strains of monkeypox.
The introduction section of the paper published in Virologica Sinica states: “Since MPXV (monkeypox) has never been associated with an outbreak in China, the viral genomic material required for qPCR detention is unavailable”.
According to retired Nurse Teacher, Dr. John Campbell, what this effectively means is that the Chinese researchers are not currently in possession of a sample of naturally occurring monkeypox, and have decided to manufacture a synthetic version through viral DNA recombination: even though, he says, the natural viral strains are readily available in African countries such as Nigeria or Congo, and the United Kingdom.
Dr. Campbell also pointed out that natural viral samples can be easily obtained from anyone with a “symptomatic” case of monkeypox.
He added that he ‘wasn’t buying’ the idea that the Chinese scientists have no other option but to synthesize their own version of the virus, adding that all they needed to do was “send someone to Nigeria”, and “slip the Nigerians a few dollars” in order to obtain a natural sample.
In order to synthesize a version of monkeypox, Campbell quoted that paper as saying a 55-kb genomic fragment of the virus is added to VL6-48B (commercially available yeast cells) which is then mixed with sugar and water. He added that this process allows researchers to brew the virus ‘like beer’, enabling them to make ‘as much as they want’.
According to the paper itself this research is being conducted at (a) State Key Laboratory of Virology, Wuhan Institute of Virology, Center for Biosafety Mega-Science, Chinese Academy for Sciences, Wuhan 430071, China.
Wuhan Institute of Virology has previously been linked to the coronavirus pandemic, although it has not been proven whether the virus that caused the global pandemic originated from the lab.
The discussion section of the paper states that the ‘DNA assembly tool applied to virological research could also raise potential security concerns especially when the assembled product contains a full set of genetic material that can be recovered into a contagious pathogen.”
“In this study, although a full length viral genome would be the ideal reference for detecting mpxv by qPCR, we only sought to assemble a 55-kb viral fragment, less than one-third of the MKXV genome”.
Campbell pointed out that any ‘unethical’ laboratories would therefore only have to synthesize the remaining two-fifths of the virus in order to create the “whole thing”.
The American NIH (National Institute of Health) features monkeypox on it’s list of funded research entitled “A randomized, placebo-controlled trial of the safety and efficacy of tecovirimat for the treatment of patients with monkeypox virus disease”.
$9,824,009 is listed as the amount of funding allocated by the NIH for the research.
Global numbers of recorded monkeypox infection currently stand at approximately 600 according to ourworldindata.org
As of 31st of May 2022 a total of 2 cases of the virus had been recorded in Ireland.
NIH funding of monkeypox research